Primary Melanoma of the Lung - A Vanishing Entity.
Primary Melanoma of the Lung - A Vanishing Entity. Acta Cytol. 2025 May 15; 1-11.
PMID: 40373758
Corrigendum to "Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist" [Modern Pathology 38 (2025) 100752].
Corrigendum to "Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist" [Modern Pathology 38 (2025) 100752]. Mod Pathol. 2025 Apr 14; 100773.
PMID: 40377506
Comparative Molecular Profiling of "Mixed Endometrioid Adenocarcinoma and Adenosarcoma" of the Uterus and Ovary: A Multi-institutional Series of 14 Cases.
Comparative Molecular Profiling of "Mixed Endometrioid Adenocarcinoma and Adenosarcoma" of the Uterus and Ovary: A Multi-institutional Series of 14 Cases. Am J Surg Pathol. 2025 Apr 07.
PMID: 40192107
A Case Report of INI1 Loss and SMARCB1 Mutation in Hereditary Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
A Case Report of INI1 Loss and SMARCB1 Mutation in Hereditary Succinate Dehydrogenase-Deficient Renal Cell Carcinoma. Int J Surg Pathol. 2025 Mar 17; 10668969251326254.
PMID: 40094795
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist.
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist. Mod Pathol. 2025 Mar 07; 38(6):100752.
PMID: 40058460
GATA3 Expression in Solid Vimentin-Negative Eosinophilic Renal Epithelial Tumors-A Comprehensive Study of 48 Tumors.
GATA3 Expression in Solid Vimentin-Negative Eosinophilic Renal Epithelial Tumors-A Comprehensive Study of 48 Tumors. Int J Surg Pathol. 2024 Nov 10; 10668969241291885.
PMID: 39523674
Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1/TSC2-Mutations: A Series of 4 cases and a review of the literature.
Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1/TSC2-Mutations: A Series of 4 cases and a review of the literature. Hum Pathol. 2024 Nov; 153:105680.
PMID: 39522702
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
PMID: 38890297
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer.
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer. J Appl Lab Med. 2024 01 03; 9(1):76-91.
PMID: 38167763
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature.
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024 Feb; 84(3):492-506.
PMID: 38084880